Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gasperini

Showing results (191-200 of 981) with videos related to

Pageof 99
Sort By:
La Radiologia Medica|December 1, 1994
[Multiple sclerosis with negative cerebrospinal fluid. Magnetic resonance differential diagnosis]S Bastianello, C Gasperini, G Ristori, et al.
Mycotoxin Research|October 13, 2020
Fungal diversity and metabolomic profiles in GM and isogenic non-GM maize cultivars from BrazilA M Gasperini, E Garcia-Cela, M Sulyok, et al.
International Journal of Molecular Sciences|May 28, 2022
Genotoxicological Characterization of (±)cis-4,4'-DMAR and (±)trans-4,4'-DMAR and Their AssociationMonia Lenzi, Sofia Gasperini, Veronica Cocchi, et al.
Journal of Affective Disorders|April 1, 1991
Morbidity risk for mood disorders in the families of borderline patientsM Gasperini, M Battaglia, P Scherillo, et al.
RSC Chemical Biology|January 19, 2026
Double-hit approach for novel glycoconjugates combining cytoplasmic glycoengineering and selective chemistryElena Palmieri, Valentina Monaci, Salvatore Durante, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 11, 2019
Dalfampridine to Improve Balance in Multiple Sclerosis: Substudy from a Randomized Placebo-Controlled TrialLuca Prosperini, Letizia Castelli, Laura De Giglio, et al.
Therapeutic Advances in Neurological Disorders|May 26, 2021
Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trialCarlo Pozzilli, Luca Prosperini, Silvia Tommasin, et al.
Expert Review of Neurotherapeutics|May 18, 2022
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosisFrancisco Javier Carod-Artal, Peyman Adjamian, Carlos Vila Silván, et al.
Food Research International (Ottawa, Ont.)|July 16, 2018
Lecithin and phytosterols-based mixtures as hybrid structuring agents in different organic phasesPaula K Okuro, Antonio A Malfatti-Gasperini, António A Vicente, et al.
Magnetic Resonance Imaging|December 19, 2000
Serial gadolinium-DTPA of spinal cord MRI in multiple sclerosis: triple vs. single doseI Yousry, M Filippi, E Walther, et al.
Pageof 99

Showing results (191-200 of 981) with videos related to

Sort By:
Pageof 99
La Radiologia Medica|December 1, 1994
[Multiple sclerosis with negative cerebrospinal fluid. Magnetic resonance differential diagnosis]S Bastianello, C Gasperini, G Ristori, et al.
Mycotoxin Research|October 13, 2020
Fungal diversity and metabolomic profiles in GM and isogenic non-GM maize cultivars from BrazilA M Gasperini, E Garcia-Cela, M Sulyok, et al.
International Journal of Molecular Sciences|May 28, 2022
Genotoxicological Characterization of (±)cis-4,4'-DMAR and (±)trans-4,4'-DMAR and Their AssociationMonia Lenzi, Sofia Gasperini, Veronica Cocchi, et al.
Journal of Affective Disorders|April 1, 1991
Morbidity risk for mood disorders in the families of borderline patientsM Gasperini, M Battaglia, P Scherillo, et al.
RSC Chemical Biology|January 19, 2026
Double-hit approach for novel glycoconjugates combining cytoplasmic glycoengineering and selective chemistryElena Palmieri, Valentina Monaci, Salvatore Durante, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 11, 2019
Dalfampridine to Improve Balance in Multiple Sclerosis: Substudy from a Randomized Placebo-Controlled TrialLuca Prosperini, Letizia Castelli, Laura De Giglio, et al.
Therapeutic Advances in Neurological Disorders|May 26, 2021
Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trialCarlo Pozzilli, Luca Prosperini, Silvia Tommasin, et al.
Expert Review of Neurotherapeutics|May 18, 2022
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosisFrancisco Javier Carod-Artal, Peyman Adjamian, Carlos Vila Silván, et al.
Food Research International (Ottawa, Ont.)|July 16, 2018
Lecithin and phytosterols-based mixtures as hybrid structuring agents in different organic phasesPaula K Okuro, Antonio A Malfatti-Gasperini, António A Vicente, et al.
Magnetic Resonance Imaging|December 19, 2000
Serial gadolinium-DTPA of spinal cord MRI in multiple sclerosis: triple vs. single doseI Yousry, M Filippi, E Walther, et al.
Pageof 99